Whole-Genome Foundation
Clinical-grade sequencing uncovers health risks that may be missed by standard clinical assessments.
Personalized Genomic Risk Maps for Lifelong Proactive Health.
MyOme Atlas uses clinically integrated whole-genome sequencing to map comprehensive health risks and guide personalized care.
1 patient sample
delivers whole-genome data
1 genome
powers lifelong health insights
4 health insights
map distinct risks
5–6 weeks
from sample to results
What MyOme Atlas delivers
Clinically Actionable Results that Inform Personalized Care Decisions
A patient's risk profile can be reanalyzed throughout their lifetime, revealing new insights as their health journey evolves and technology advances. Results help guide personalized screening, medication, and lifestyle recommendations that can reduce risks and prevent disease — even before symptoms arise.
Actionable Reports
Clinician-designed reports translate genomic risk into guideline-aligned metrics and clear next steps, with interpretation support and patient genetic counseling included.
Lifelong Value
Genomic datasets can be reanalyzed over a patient’s lifetime, revealing new insights as health, science, and technology evolve.
Proactive health tests
Explore the Atlas Portfolio
Uncover actionable risk variants across a curated, rigorously evidenced set of genes linked to 40+ health conditions.
Learn More
Reveal pharmacogenomic variants that guide safer, more effective prescribing across 70+ medications.
Learn More
Map integrated risk for coronary artery disease and type 2 diabetes with cross-ancestry accuracy.
Learn More
Detect elevated risk early for breast and prostate cancer with whole-genome risk mapping.
Learn MoreMap genomic risk, guide lifelong health.
Ready to bring proactive, genomics-informed care to your patients? Get started with MyOme Atlas today.